New mechanisms of action of irreversible monoamine oxidase type B inhibitors.
作者信息
Li X M, Juorio A V, Paterson I A, Boulton A A
出版信息
J Psychiatry Neurosci. 1993 Jul;18(4):199-200.
Abstract
摘要
相似文献
1
New mechanisms of action of irreversible monoamine oxidase type B inhibitors.不可逆性单胺氧化酶B型抑制剂的新作用机制
J Psychiatry Neurosci. 1993 Jul;18(4):199-200.
2
Recent advances in Parkinson's disease therapy: use of monoamine oxidase inhibitors.帕金森病治疗的最新进展：单胺氧化酶抑制剂的应用
Expert Rev Neurother. 2005 Nov;5(6):811-21. doi: 10.1586/14737175.5.6.811.
3
MAO type B inhibitors as adjunct to L-dopa therapy.B型单胺氧化酶抑制剂作为左旋多巴治疗的辅助药物。
Adv Neurol. 1987;45:127-36.
4
MAO-B inhibitors in Parkinson's disease.帕金森病中的单胺氧化酶B抑制剂
Adv Neurol. 1993;60:666-71.
5
Critical role of MAO inhibition in Parkinson's disease.
Adv Neurol. 1987;45:107-10.
6
[History of deprenyl--the first selective inhibitor of monoamine oxidase type B].[司来吉兰的历史——首个单胺氧化酶B型选择性抑制剂]
Vopr Med Khim. 1997 Nov-Dec;43(6):482-93.
7
Monamine oxidase inhibitors: current and emerging agents for Parkinson disease.单胺氧化酶抑制剂：帕金森病的现有及新型药物
Clin Neuropharmacol. 2007 May-Jun;30(3):150-68. doi: 10.1097/01.wnf.0000240956.49315.be.
8
Monoamine oxidase-B inhibition in the treatment of Parkinson's disease.单胺氧化酶B抑制剂在帕金森病治疗中的应用
Pharmacotherapy. 2007 Dec;27(12 Pt 2):174S-185S. doi: 10.1592/phco.27.12part2.174S.
9
MAO-B inhibitors for the treatment of Parkinson's disease.用于治疗帕金森病的单胺氧化酶B抑制剂。
Mov Disord. 2002;17 Suppl 4:S38-44. doi: 10.1002/mds.5559.
10
Are there MAO inhibitors specific for dopamine metabolism?是否存在对多巴胺代谢具有特异性的单胺氧化酶抑制剂？
Adv Biochem Psychopharmacol. 1977;16:349-58.
本文引用的文献
1
Aromatic L-amino acid decarboxylase activity of the rat retina is modulated in vivo by environmental light.大鼠视网膜的芳香族L-氨基酸脱羧酶活性在体内受环境光调节。
J Neurochem. 1988 Nov;51(5):1560-4. doi: 10.1111/j.1471-4159.1988.tb01125.x.
2
The effect of repeated doses of (-) deprenyl on the dynamics of monoaminergic transmission. Comparison with clorgyline.重复剂量的（-）司来吉兰对单胺能传递动力学的影响。与氯吉兰的比较。
Pol J Pharmacol Pharm. 1986 Jan-Feb;38(1):57-67.
3
Possible mechanism of action of deprenyl in parkinsonism.司来吉兰在帕金森病中的可能作用机制。
Lancet. 1990 Jul 21;336(8708):183. doi: 10.1016/0140-6736(90)91709-j.
4
Monoamine oxidase inhibitors prevent striatal neuronal necrosis induced by transient forebrain ischemia.单胺氧化酶抑制剂可预防短暂性前脑缺血诱导的纹状体神经元坏死。
Neurosci Lett. 1991 May 27;126(2):175-8. doi: 10.1016/0304-3940(91)90547-7.
5
Regulation of aromatic L-amino acid decarboxylase by dopamine receptors in the rat brain.大鼠脑中多巴胺受体对芳香族L-氨基酸脱羧酶的调节作用。
J Neurochem. 1992 Feb;58(2):636-41. doi: 10.1111/j.1471-4159.1992.tb09765.x.
6
Parkinson's disease.帕金森病。
Lancet. 1990 Apr 21;335(8695):948-52. doi: 10.1016/0140-6736(90)91006-v.
7
Rescue of dying neurons: a new action for deprenyl in MPTP parkinsonism.挽救濒死神经元：司来吉兰在MPTP帕金森症中的新作用
J Neurosci Res. 1991 Dec;30(4):666-72. doi: 10.1002/jnr.490300410.
8
Attenuation of hypoxic response in cerebral microcirculation following deprenyl.司来吉兰治疗后脑微循环缺氧反应的减弱
Int J Microcirc Clin Exp. 1992 Aug;11(3):287-95.
9
Gene expression of aromatic L-amino acid decarboxylase in cultured rat glial cells.
J Neurochem. 1992 Sep;59(3):1172-5. doi: 10.1111/j.1471-4159.1992.tb08363.x.
10
Specific irreversible monoamine oxidase B inhibitors stimulate gene expression of aromatic L-amino acid decarboxylase in PC12 cells.特异性不可逆单胺氧化酶B抑制剂可刺激PC12细胞中芳香族L-氨基酸脱羧酶的基因表达。
J Neurochem. 1992 Dec;59(6):2324-7. doi: 10.1111/j.1471-4159.1992.tb10127.x.
Zotero 插件